The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2025

Filed:

Jun. 16, 2021
Applicant:

Aeromics, Inc., New Haven, CT (US);

Inventors:

Marc F. Pelletier, Shaker Heights, OH (US);

Paul Robert McGuirk, Spring Hill, FL (US);

George William Farr, Rocky River, OH (US);

Robert Zamboni, Beaconsfield, CA;

John Colucci, Kirkland, CA;

Helmi Zaghdane, Pincourt, CA;

Assignee:

Aeromics, Inc., New Haven, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/661 (2006.01); A61K 9/00 (2006.01); A61K 31/167 (2006.01); A61K 31/222 (2006.01); A61K 31/5375 (2006.01); A61K 47/18 (2017.01); C07F 9/09 (2006.01);
U.S. Cl.
CPC ...
A61K 31/661 (2013.01); A61K 9/0019 (2013.01); A61K 31/167 (2013.01); A61K 31/222 (2013.01); A61K 31/5375 (2013.01); A61K 47/18 (2013.01); C07F 9/09 (2013.01);
Abstract

Provided are novel prodrug salts of selective aquaporin inhibitors, their use as pharmaceuticals, and pharmaceutical compositions comprising them, and novel processes for their synthesis and novel intermediates for use in their synthesis. Also provided is use of a compound for the prophylaxis, treatment, and control of aquaporin-mediated conditions. Aquaporin inhibitors, e.g., inhibitors of AQP4 and/or AQP2, may be of utility in the treatment or control of diseases of water imbalance, for example edema (particularly edema of the brain and spinal cord), hyponatremia, and excess fluid retention, as well as diseases such as epilepsy, retinal ischemia and other diseases of the eye, myocardial ischemia, myocardial ischemia/reperfusion injury, myocardial infarction, myocardial hypoxia, congestive heart failure, sepsis, and neuromyelitis optica, as well as migraines.


Find Patent Forward Citations

Loading…